29.05.2013 19:20 Uhr, Quelle: Wallstreet online

DGAP-Adhoc: GSK and Genmab Announce Positive Top-line Results from Pivotal Study of ARZERRA(r) (ofatumumab) Combined with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia

Genmab A/S 29.05.2013 19:05 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this …

Weiterlesen bei Wallstreet online

Digg del.icio.us Facebook email MySpace Technorati Twitter

JustMac.info © Thomas Lohner - Impressum - Datenschutz